These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2566008

  • 1. Hepatitis B vaccine in the expanded programme of immunisation: The Gambian experience. The Gambia Hepatitis Study Group.
    Lancet; 1989 May 13; 1(8646):1057-9. PubMed ID: 2566008
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Integration of hepatitis B vaccination into rural African primary health care programmes.
    Schoub BD, Johnson S, McAnerney JM, Blackburn N, Kew MC, McCutcheon JP, Carlier ND.
    BMJ; 1991 Feb 09; 302(6772):313-6. PubMed ID: 1825799
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B.
    Chotard J, Inskip HM, Hall AJ, Loik F, Mendy M, Whittle H, George MO, Lowe Y.
    J Infect Dis; 1992 Oct 09; 166(4):764-8. PubMed ID: 1388196
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A, Study Group.
    Lancet; 1992 Oct 09; 366(9494):1379-84. PubMed ID: 16226616
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct 09; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 13. What level of hepatitis B antibody is protective?
    Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC.
    J Infect Dis; 1999 Feb 09; 179(2):489-92. PubMed ID: 9878036
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.
    Rey-Cuille MA, Njouom R, Bekondi C, Seck A, Gody C, Bata P, Garin B, Maylin S, Chartier L, Simon F, Vray M.
    Pediatr Infect Dis J; 2013 Oct 09; 32(10):1110-5. PubMed ID: 23694839
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT, Goldstein ST, Tufa J, Tauillii S, Margolis HS, Mahoney FJ.
    Pediatr Infect Dis J; 2003 Feb 09; 22(2):157-63. PubMed ID: 12586980
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunisation of neonates at high risk of hepatitis B in England and Wales: national surveillance.
    Polakoff S, Vandervelde EM.
    BMJ; 1988 Jul 23; 297(6643):249-53. PubMed ID: 2970879
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.